DRAM1 and non-small cell lung carcinoma: Taken together, these results suggest that DRAM1 significantly inhibits the oncogenetic potential of NSCLC cells in vivo and in vitro, including the inhibition of growth, EMT, and increasing TKI sensitivity in vitro and in vivo.